The Food and Drug Administration (FDA) allowed people with compromised immune systems to get a third dose of the COVID vaccine. As per the experts, the change in FDA regulation is specific to patients who have been unable to mount an adequate immune response against the virus, even after being fully vaccinated. The additional dose will provide these patients with levels of protection seen in people without weakened immune systems.
According to the reports, the FDA stated that the additional doses are for certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise and the amended EUAs apply only to the third dose of the Pfizer and Moderna vaccines.
The FDA further stated that the additional doses are for certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise and this applies only to third doses of the Pfizer and Moderna vaccines.
The FDA’s change does not apply to the general population. Such booster doses would be given only if protection from the vaccines was shown to fall below a certain threshold — though scientists are still working to determine precisely what that threshold is. The immunocompromised, however never really got a good response to begin with
Do you find this post useful?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?